Start your weight loss journey today. First month as low as $134.Start Now
Prescribed by real doctors. 100% online, delivered to your door.Get Started
No insurance needed. Quality care for everyone.Get Started
GoodGirlRx
LoginGet Started
Menu
Savannah Chrisley

Created by Savannah.
Made for you.

Get Started

Explore

Top Treatments

SemaglutideSupply Available

SemaglutideRx

Learn More
TirzepatideSupply Available

TirzepatideRx

Learn More
Semaglutide PillsNo Needles

Semaglutide PillsRx

Learn More
Tirzepatide PillsNo Needles

Tirzepatide PillsRx

Learn More
NAD+ InjectionAnti-Aging

NAD+ InjectionRx

Learn More

Learn

About GoodGirlRxFounders LetterBlogHelp Center

Shop

GoodGirlRx Merch

Content

Savannah Chrisley
Join Me
SemaglutideSupply Available

SemaglutideRx

GLP-1 Receptor Agonist

Get StartedLearn More

Home / Science

How GLP-1 medications actually work (without the jargon)

James T.

Written by James T.

Published February 18, 2026

How GLP-1 medications actually work (without the jargon)

GLP-1 is one of those terms that got big on TikTok before anyone really explained it. Here's the plain-English version of what these medications do inside your body, why your appetite feels different, and where the science is actually solid.

What a GLP-1 is, really

GLP-1 stands for glucagon-like peptide-1. It's a hormone your gut already makes every time you eat. Its job is to tell your pancreas to release insulin, tell your brain you're full, and slow down how fast food leaves your stomach. Medications in this class are called GLP-1 receptor agonists — a long way of saying they mimic the hormone your body already uses.

Did you know?

Your body already does this

Your gut has been releasing GLP-1 after every meal since the day you were born. These medications don't introduce a foreign signal — they amplify one that's already part of your natural digestion.

The three things it does at once

  1. Tells your pancreas to release insulin only when blood sugar rises — so it's active when you eat, quiet when you don't.
  2. Slows gastric emptying — food leaves your stomach more slowly, which is why fullness lasts longer.
  3. Acts in the brain on appetite and reward centers, which is the part most people describe as food noise getting quieter.
Woman drinking water in a sunlit kitchen
Slower gastric emptying is also why hydration becomes a bigger deal on a GLP-1.

GLP-1 vs GLP-1 + GIP

Semaglutide targets GLP-1 receptors only. Tirzepatide is a dual agonist — it targets both GLP-1 and GIP receptors. GIP (glucose-dependent insulinotropic polypeptide) is a second gut hormone that plays a role in how your body handles fat. Activating both pathways is the reason tirzepatide is often described as a dual-action therapy.

Active ingredientTargetsBranded as
SemaglutideGLP-1Ozempic®, Wegovy®
TirzepatideGLP-1 + GIPMounjaro®, Zepbound®
LiraglutideGLP-1Saxenda®, Victoza®
Active-ingredient comparison
“The strongest tool in the toolbox is the one your provider personalizes to your body — not the one with the biggest headline.”
— Maya P., Health Editor

What the research actually shows

Published clinical efficacy data comes from trials run on the FDA-approved branded products: the STEP trials for semaglutide (Wegovy®), and the SURMOUNT trials for tirzepatide (Zepbound®). Those trials studied the specific branded formulations in carefully controlled dose ranges, paired with lifestyle support. Any compounded formulation is a separate product, is not FDA-reviewed, and the branded-trial results do not transfer to it.

Important

What to ignore

Anyone telling you a medication will work exactly the same for every body is selling, not teaching. Titration, side-effect profile, and results are individual — that's why a licensed provider guides the whole thing.

Not sure which one is right for you?

Our Find My Treatment tool matches you with a starting point in about 5 minutes.

Find my treatment →

The bottom line

GLP-1 medications don't trick your body. They amplify a signal it already uses to regulate appetite and blood sugar. The work you do around them — sleep, protein, movement, water — decides how much of the benefit sticks. That's why you're still the most important variable.

Sources & disclosures

  1. Wilding JPH et al., STEP 1 Trial (semaglutide in adults with overweight or obesity). New England Journal of Medicine, 2021.
  2. Jastreboff AM et al., SURMOUNT-1 Trial (tirzepatide in adults with obesity). New England Journal of Medicine, 2022.
  3. FDA Center for Drug Evaluation and Research. Clinical Review: Wegovy® Approval Package, 2021.
  4. Compounded medications are not reviewed by the FDA. Trial data from branded products does not apply to compounded formulations.

Share this article

Confident woman in white activewear showcasing fit physique and healthy lifestyle for wellness goals

Ready to start your journey?

Complete your free online visit and see if GLP-1 treatment is right for you.

Get Started

Related Articles

What I learned in my first 90 days (Real Talk)

Savannah ChrisleySavannah Chrisley · Mar 28, 2026
What I learned in my first 90 days (Real Talk)

Beating the 12-week plateau: what actually works

Maya P.Maya P. · Jan 9, 2026
Beating the 12-week plateau: what actually works

More from the blog

EducationHealthNutritionReal TalkScienceTipsWeight Loss

Popular

SemaglutideTirzepatideOzempic®Wegovy®NAD+

Top Articles

What I learned in my first 90 days (Real Talk)Beating the 12-week plateau: what actually worksProtein goals on a GLP-1: the simple formula
GoodGirlRx
LegitScript Certified

Stay in the know

Popular

TirzepatideSemaglutideNAD+SermorelinOzempic®Wegovy®

Company

Patient PortalFounder's LetterAboutBlogHelp + FAQReturns & RefundsShipping Policy

Legal

Privacy PolicyImportant Safety InformationMy Health My Data Privacy PolicyTerms of ServiceAll systems operational
GoodGirlRx
LegitScript Certified

Stay in the know

TirzepatideSemaglutideNAD+SermorelinOzempic®Wegovy®
Patient PortalFounder's LetterAboutBlogHelp + FAQReturns & RefundsShipping Policy
Privacy PolicyImportant Safety InformationMy Health My Data Privacy PolicyTerms of ServiceAll systems operational

The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. The products offered by GoodGirlRx are compounded medications prepared by independent, licensed compounding pharmacies. These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medications. They are not substitutes for FDA-approved medications such as Mounjaro®, Zepbound®, Wegovy®, or Ozempic®. Any claims regarding effectiveness, safety, or weight loss benefits relate only to general mechanisms of the active ingredients (e.g., tirzepatide or semaglutide) and do not pertain to GoodGirlRx’s specific compounded formulations. These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider. By purchasing or using these products, you acknowledge and accept these terms. Product images shown on this website are for illustrative purposes only. Actual product packaging, labeling, and appearance may differ. GoodGirlRx is not a pharmacy and does not manufacture, compound, or dispense medications. Good Girl, LLC dba GoodGirlRx  |  1005 17th Avenue South, Suite 900, Nashville, TN 37212

2026 © Good Girl, LLC. All rights reserved.